尾加压素Ⅱ促兔肺动脉平滑肌细胞增殖及机理探讨

目的:探讨尾加压素Ⅱ(urotensin Ⅱ,U-Ⅱ)对兔肺动脉平滑肌细胞(PASMCs)的作用及机理。方法:采用植块法培养家兔PASMCs,以MTT测定和[³H]-胸腺嘧啶核苷([³H]-TdR)掺入法观察U-Ⅱ对PASMCs增殖的影响,加入不同浓度的几种细胞内信号转导阻断剂,观察对U-Ⅱ效应的影响。 结果:U-Ⅱ(10^-9 mol/L-10^-7 mol/L)浓度依赖地促进PASMCs的A值增加及 -TdR掺入,以10^-7 mol/L U-Ⅱ的作用最明显,A值和[³H]-TdR掺入量分别较对照组高42.9%和68.5%(P＜0.05) 。10^-10 mol/L U-Ⅱ对PASMCs增殖无作用。尼卡地平、W₇、H₇、PD₉₈₀₅₉在一定浓度范围内(10^-7 mol/L-10^-5 mol/L)均可以浓度依赖地抑制U-Ⅱ诱导的PASMCs的A值增加及[³H]-TdR掺入增加。在浓度为10^-5 mol/L时,其抑制作用最明显,A值的抑制率分别为42.3%、19.6%、23.2%和10.5%(P＜0.05), -TdR掺入量的抑制率分别为46.6%、9.8%、21.7%和14.7%(P＜0.05 )。 结论: U-Ⅱ具有较强的促PASMCs增殖的作用,其诱导PASMCs增殖是通过Ca²⁺、CaM、PKC、MAPK来介导的。     

雌激素对培养的兔平滑肌细胞增殖与移行的影响

目的: 探讨雌激素对培养的兔平滑肌细胞增殖与移行的影响。方法: 分别测定不同浓度雌激素作用下兔血管平滑肌细胞[³H]-TdR掺入量、增殖细胞核抗原(PCNA)的表达、血管平滑肌细胞(VSMC)移行的变化。结果: 低浓度(1 nmol/L)的雌激素组的培养细胞[³H]-TdR掺入量及VSMC平均光密度值、VSMC移行细胞数与对照组相比无明显差异(P>0.05), 较高浓度(10 nmol/L、100 nmol/L)的雌激素可以显著降低培养的[³H]TdR掺入量及培养VSMC平均光密度值, 并能显著减少VSMC移行细胞数目(P<0.01)。结论: 雌激素可抑制血管平滑肌细胞的增殖与移行, 从而发挥抗动脉粥样硬化作用。     

白三烯D4在促进培养的人气管 平滑肌细胞增殖中的作用

目的和方法:研究白三烯D₄(LTD₄)是否剌激培养的人气管平滑肌细胞(ASMC)增殖。将分离的人ASMC进行传代培养,在培养基中加入各种浓度的LTD₄,计数细胞并测定 [³H]-胸腺嘧啶核苷([³H]-TdR)掺入量和三磷酸肌醇(IP₃)累积量。结果: LTD₄在一定范围内(0.1 nmoL·L^-1~10 nmoL·L^-1)以浓度依赖的方式增加人ASMC(P＜0.01)。LTD₄也增加[³H]-TdR的掺入量和IP₃累积量(P＜0.01)。磷脂酶C抑制剂新霉素(1 μmol·L^-1)阻止IP₃累积量的增加(P＜0.01)。结论:LTD₄剌激培养的人ASMC增殖并且可能在哮喘的气道重塑中起了作用。     

纤维粘连蛋白对培养的自发性高血压大鼠心肌成纤维细胞增殖及胶原合成的影响

目的:观察纤维粘连蛋白(FN)对培养的SHR和WKY大鼠心肌成纤维细胞(CFb, CFb_SHR, CFb_WKY)增殖及胶原合成的影响。方法:CFb取自12周的SHR和WKY大鼠, 采用组织块贴壁法培养, 以直接细胞计数法和 [³H]-TdR掺入率反映细胞增殖, 以[³H]-脯氨酸([³H]-proline)掺入率反映胶原合成。使用FN(5 μg/cm²)预先处理24孔培养板。 结果: 与0.4% FCS对照组相比, 经72 h孵育FN明显促进CFb_SHR和CFb_WKY细胞数增多, 分别为对照组的163.75%(CFb_SHR)和170.42%(CFb_WKY)。FN促进CFb_SHR和CFb_WKY [³H]-TdR掺入增加。FN促进CFb_SHR和CFb_WKY[³H]-proline掺入增加。 结论:FN促进SHR和WKY大鼠的CFb增殖及胶原合成。     

金属硫蛋白抑制同型半胱氨酸诱导的大鼠血管平滑肌细胞增殖

目的:研究金属硫蛋白(MT)对同型半胱氨酸(Hcy)诱导大鼠血管平滑肌细胞(vascularsmoothmusclecells,VSMCs)增殖的影响及其作用机制。方法:以[³H]-TdR掺入法测定VSMCs增殖程度,免疫沉淀法测定VSMCs内丝裂素活化蛋白激酶(MAPK)活性,[¹⁰⁹Cd]-血红蛋白饱和法测定MT含量,硫代巴比妥酸法测定丙二醛(MDA)含量,NADH氧化法测定乳酸脱氢酶(LDH)漏出量。结果:Hcy(10^-6-10^-4mmol/L)呈浓度依赖性的刺激培养大鼠VSMCs[³H]-TdR掺入,0.1mmol/LHcy刺激[³H]-TdR掺入比对照组高4.2倍(P＜0.01)。Hcy亦呈浓度依赖性地激活VSMCsMAPK活性、增加细胞MDA的生成和LDH的漏出(P均<0.01)。单独MT孵育,对VSMCs的上述指标均无明显影响(P＞0.05)。但MT(10^-6-10^-4mol/L)呈浓度依赖性抑制100μmol/LHcy的促增殖效应(r=0.98,P＜0.01)。MT显著抑制Hcy对VSMCs的MAPK活性、MDA生成和LDH漏出的激活作用(均P＜0.01)。以0.5mmol/LZnCl₂预孵育6h后,VSMCsMT含量比非诱导细胞高5.7倍(P＜0.01),这种内源性MT高表达的细胞,显著抵抗Hcy刺激的-TdR掺入和MAPK激活;抑制Hcy的促细胞MDA生成与LDH漏出效应(均P＜0.01)。结论:MT能有效抑制Hcy促大鼠VMSCs增殖作用,其机制可能与MT拮抗Hcy对MAPK的激活和其抗氧化作用有关。     

红景天甙对低氧培养的兔肺动脉平滑肌细胞增殖的抑制作用

目的:研究红景天甙(Salidroside,Sal)对低氧(3%)条件下兔肺动脉平滑肌细胞(PASMC)增殖、DNA合成、细胞内钙离子浓度的影响。方法:应用细胞培养、四唑盐比色试验(MTT)、[³H]-胸腺嘧啶核苷([³H]-TdR)掺入试验、Fluo-3和激光扫描共聚焦显微术测定细胞内Ca²⁺浓度等方法。结果:低氧24h可直接刺激PASMC,使MTT的A值增加62%(P＜0.05),[³H][³H]-TdR掺入量增加138%(P＜0.01)。在低氧的PASMC培养液中加入Sal(32×10^-5mol/L)可抑制低氧的这种促增殖作用,与低氧组相比MTT的A值下降29%(P＜0.05),[³H][³H]-TdR掺入量下降37%。在低氧的PASMC培养液中加入钙通道阻滞剂verapamil也可抑制低氧的促增殖作用,与低氧组相比较,MTT的A值下降23%(P＜0.05),[³H][³H]-TdR掺入量下降51%(P＜0.01)。PASMC的低氧培养可使细胞内Ca²⁺浓度明显增加(P＜0.05),Sal可抑制低氧所致的细胞内Ca²⁺浓度的上升。结论:红景天甙可抑制低氧促进PASMC增殖、DNA合成的作用,其机制可能与抑制低氧时细胞内Ca²⁺浓度增加有关。     

硫化氢对培养的大鼠主动脉平滑肌细胞增殖的抑制作用

目的:探讨硫化氢(H₂S)对内皮素-1(ET-1)诱导的血管平滑肌细胞(VSMC)增殖的影响及丝裂原激活的蛋白激酶(MAPK)信号转导途径的作用。方法:体外培养雄性SD大鼠主动脉VSMC, 将细胞分成对照组、血清组、内皮素组、NaHS组、血清+NaHS组和内皮素+NaHS组进行研究, 以不同浓度梯度NaHS处理VSMC, 观察对VSMC[³H]-TdR掺入和MAPK活性的影响。结果:加入5×10^-5-5×10^-4mol/LNaHS可明显浓度依赖性地抑制由内皮素诱导的VSMC增殖, 其[³H]-TdR掺入量减低, 抑制率分别为16.8%-37.4%(P＜0.01), 其MAPK活性明显减低, 抑制率为7.4%-33.6%(P＜0.05或P＜0.01)。结论:H₂S对内皮素诱导的VSMC增殖有抑制作用, 同时使MAPK活性下调。推测H₂S对VSMC增殖的抑制效应可能由MAPK信号途径所介导。     

酪氨酸蛋白激酶在自发性高血压大鼠血管平滑肌细胞增殖肥大中的作用

目的: 明确自发性高血压大鼠血管平滑肌细胞(SHR-VSMC)增殖与血小板源生长因子-AA(PDGF-AA)、PDGF-α受体表达的关系及酪氨酸蛋白激酶在其中的作用。方法: 在培养的血管平滑肌细胞中,采用免疫印迹(Westernblot)、[³H]-TdR及[³H]-Leu掺入等方法,观察在不同来源大鼠(SHR/WKY)血管平滑肌细胞中,PDGF-AA、PDGF-α受体及PDGF-β受体表达的差异性;在PDGF-AA刺激下细胞的增殖、肥大反应及酪氨酸激酶抑制剂(genistein)对其的影响。结果: SHR-VSMC中PDGF-AA、PDGF-α受体蛋白表达明显高于WKY-VSMC,而PDGF-β受体蛋白表达在SHR-VSMC与WKY-VSMC无明显差异;在不同浓度PDGF-AA刺激下,PCNA及[³H]掺入率在SHR-VSMC明显增强且呈剂量依赖性;酪氨酸激酶抑制剂(genistein)明显抑制PCNA表达及[³H]掺入。结论: 自发性高血压大鼠VSMCPDGF-A链及其α受体的自发性增高,可能是导致SHR-VSMC异常增殖、肥大,从而触发血管反应性和血管构型变化的重要原因之一;酪氨酸蛋白激酶介导的信号转导在其中发挥重要作用。     

人参单体皂甙Rh2对前列腺癌细胞株PC-3M细胞移行周期的影响

目的:探讨Rh₂对体外培养的PC-3M细胞移行周期的影响。方法:应用[³H]-TdR掺入法和流式细胞仪测定DNA含量及进行细胞周期的分析。结果:PC-3M细胞的[³H]-TdR掺入量明显少于对照组(P＜0.01);流式细胞仪测定G₁期细胞数百分比明显高于对照组。结论:Rh₂可使PC-3M细胞增殖周期阻滞在G₁期,肿瘤细胞增殖减慢。     

奥曲肽抑制肝星状细胞增殖及细胞外基质合成

目的:探讨奥曲肽对肝星状细胞(HSC)增殖与细胞外基质(ECM)合成的影响。方法:采用胶原酶二步原位灌注法分离、培养大鼠HSC,并分别给予转化生长因子1(TGFβ1)(2.5μg·L^-1)、奥曲肽(Oct)(0.01-10μg·L^-1)或TGFβ1(2.5μg·L^-1)+Oct(0.01-10mg·L^-1)干预,分别用MTT法、[³H]-TdR和[³H]-脯氨酸掺入法及放射免疫法检测各处理组HSC增殖及ECM合成水平。结果:Oct能不同程度抑制HSC[³H]-TdR掺入和增殖;能够显著抑制体外培养HSC[³H]-脯氨酸掺入,降低上清液透明质酸(HA)、层粘连蛋白(LN)和IV型胶原(CIV)水平;TGFβ1能够诱导HSC表达ECM上调,Oct能够阻断TGFβ1对HSC的调控作用。结论:Oct能够有效地抑制HSC增殖及ECM合成与分泌。     

胍基丁胺抑制低氧培养大鼠肺动脉平滑肌细胞增殖

目的：观察胍基丁胺对低氧培养大鼠肺动脉平滑肌细胞(PASMCs)增殖的影响。 方法： 采用组织块贴壁法原代培养大鼠PASMCs，取对数生长期PASMCs分对照组和胍基丁胺组，比色法测定细胞培养液中乳酸脱氢酶（LDH）活力，液闪计数仪测定［3H］-TdR掺入量，流式细胞仪测定细胞周期，图像分析法测定增殖细胞核抗原含量（PCNA）作为细胞增殖的指标。 结果： 常氧和低氧(2.5% O2)培养时，胍基丁胺组LDH活力与对照组LDH活力均无显著差异（P>0.05）；与单纯低氧组相比，50 μmol/L胍基丁胺可显著减少低氧培养PASMCs的［3H］-TdR掺入量(P<0.01)。随着胍基丁胺浓度从50 μmol/L逐渐增加至500 μmol/L，大鼠PASMCs ［3H］-TdR的掺入量亦随之减少(P<0.01)。与单纯低氧组相比，胍基丁胺可显著减少低氧培养PASMCs的PCNA的含量(P<0.01)，使G0/G1期细胞比例显著增加，G2/M期细胞比例显著减少(P<0.01)。 结论： 胍基丁胺对PASMCs不产生明显的细胞毒性作用；胍基丁胺可抑制低氧培养大鼠PASMCs的增殖，这种抑制作用呈剂量依赖性。     

半边莲生物碱抑制内皮素-1诱导的人脐动脉平滑肌细胞增殖

目的：探讨半边莲生物碱(LCLA)对内皮素-1（ET-1）诱导人脐动脉平滑肌细胞（VSMC）增殖的抑制效应及其作用机制。 方法： 采用细胞计数、［3H］-TdR掺入、流式细胞术、免疫细胞化学染色及Fura-3/AM 荧光探针标记方法检测VSMC增殖；并用台盼蓝拒染、乳酸脱氢酶（LDH）检测方法观察LCLA对VSMC的毒性反应。 结果： LCLA(100、200和400 mg/L)、BQ-123(10-6mol/L)、ST(10-7mol/L)均抑制ET-1所诱导的VSMC增殖（均P＜0.05）：明显降低VSMC的细胞数目、［3H］-TdR掺入量、S期和G2/M期的数目百分比，增加G0/G1期的数目百分比；减弱细胞内增殖细胞核抗原（PCNA）的表达强度和Ca2+荧光强度；LCLA的抑制作用存在明显的剂量依赖关系，但对VSMC存活率和LDH释放量均没有影响。 结论： LCLA浓度依赖性地抑制ET-1所诱导的人脐动脉VSMC增殖，其机制与降低VSMC内Ca2+含量有关。     

Proliferating cell nuclear antigen immunohistochemistry in rat aorta after balloon denudation. Comparison with thymidine and bromodeoxyuridine labeling.

The authors compared detection of proliferating vascular smooth muscle cells (SMC) in vitro and in vivo with proliferating cell nuclear antigen (PCNA) immunohistochemistry and two established methods: [3H]thymidine autoradiography and bromodeoxyuridine immunohistochemistry. Labeling with [3H]thymidine and bromodeoxyuridine of rat vascular SMC in culture stained 11% +/- 2% and 11% +/- 1% of cells, and PCNA immunohistochemistry 22% +/- 2% of cells. Proliferation in the media of the denuded rat aortae was highest 3 days after denudation: 4.2%, 3.8%, and 4.7% of labeled cells with [3H]thymidine, bromodeoxyuridine, and PCNA, respectively. In the intima, proliferation was highest 7 days after denudation with 42% [3H]thymidine, 40% bromodeoxyuridine, and 46% PCNA-positive cells. With double labeling, all [3H]thymidine-positive cells were PCNA positive, whereas some cells were only positive for PCNA. The authors conclude that PCNA immunohistochemistry compares favorably with [3H]thymidine autoradiography, and bromodeoxyuridine immunohistochemistry.     

养血清脑血清拮抗溶血磷脂酸诱导大鼠血管平滑肌细胞增殖

目的:观察养血清脑药物血清对溶血磷脂酸(LPA)诱导的大鼠血管平滑细胞(VSMC)增殖作用的影响。方法:在培养的大鼠平滑肌细胞上,测定[³H]-胸腺嘧啶核苷([³H]-thymidine,[³H]-TdR)掺入、丝裂素活化蛋白激酶(mitogen-activated protein kinase,MAPK)活性及脂质过氧化终产物丙二醛(malonyldialdehyde,MDA)含量。结果:1×10^－9、1×10^－8和1×10^－7 mol·L^-1 LPA呈浓度依赖性引起VSMC[³H]-TdR掺入量、MAPK活性及MDA含量增加。5％、10％和15％养血清脑血清预孵育使1×10^－7 mol·L^-1 LPA诱导VSMC[³H]-TdR掺入量分别下降23.0％、42.0％和52.0％(P<0.01);使VSMC MAPK的活性分别下降13.9％(P<0.05)、29.6％(P<0.01)和48.9％(P<0.01);使细胞MDA含量分别下降19.4％、24.7％和43.2％(P<0.01)。结论:LPA呈浓度依赖性引起VSMC增殖及脂质过氧化,VSMC增殖与其细胞内信号转导MAPK途径有关。养血清脑血清可有效地拮抗LPA诱导的VSMC增殖、MAPK激活和脂质过氧化损伤。     

脱氧核酶抑制人脐动脉平滑肌细胞增殖

目的：观察增殖细胞核抗原（PCNA）基因特异性的10-23脱氧核酶（DNAzyme）对人脐动脉平滑肌细胞（HUASMC）增殖的影响。 方法： 设计合成针对PCNA基因起始密码AUG的DNAzyme，应用脂质体转染法将其转入体外培养的HUASMC。检测DNAzyme干预HUASMC 2 d后［3H］-TdR的掺入量；通过四甲基偶氮唑蓝（MTT）比色法分析HUASMC的增殖；采用流式细胞仪检测细胞周期。 结果： 1.0 μmol/L DNAzyme干预HUASMC 2 d后，［3H］-TdR的掺入量低于对照组（P<0.05）。1.0 μmol/L的DNAzyme和反义寡聚核苷酸（ASODN）组处理2、3和5 d后，MTT比色吸光度值低于对照组（均P<0.01）。DNAzyme对细胞增殖的抑制呈剂量依赖性。细胞干预2 d后，DNAzyme、ASODN和对照组的G0/G1期细胞的比率分别为73.8%、54.7%和41.1%。 结论： 针对PCNA的DNAzyme能有效抑制HUASMC的体外增殖。     

Hyperglycaemia inhibits thymidine incorporation and cell growth via protein kinase C,mitogen-activated protein kinases and nitric oxide in human umbilical vein endothelium

An elevated extracellular concentration of D-glucose (i.e. hyperglycaemia) inhibits cell proliferation and incorporation of the endogenous nucleoside thymidine into DNA in human umbilical vein endothelial cells (HUVECs). Cells in their log-phase of growth (3.7 +/- 0.3 days, n = 27) incubated for 30 min with 25 mM D-glucose, but not with equimolar concentrations of L-glucose or D-mannitol, exhibited reduced [3H]thymidine incorporation and cell growth rate, with no change in cell viability (> 98 %), total DNA, protein content or cell volume. Incubation with D-glucose activated protein kinase C (PKC), endothelial NO synthase (eNOS), p42 and p44 mitogen-activated protein kinases (p42/44(mapk)), but inhibited superoxide dismutase (SOD). Incubation with D-glucose also increased cGMP and cAMP levels. The effect of D-glucose was blocked by the PKC inhibitor calphostin C, the MAP kinase kinase 1/2 (MEK1/2) inhibitor PD-98059, the eNOS inhibitor L-NAME, the protein kinase G (PKG) inhibitor KT-5823 and the protein kinase A (PKA) inhibitor KT-5720. In the presence of 5 mM D-glucose, [3H]thymidine incorporation and cell growth were reduced by the PKC activator phorbol 12-myristate 13-acetate (PMA), the NO donor S-nitroso-N-acetyl-L,D-penicillamine (SNAP), dibutyryl cGMP, dibutyryl cAMP and the Ca2+ ionophore A-23187. The effect of A-23187 was blocked by calphostin C and PD-98059. D-Glucose-dependent inhibition of thymidine incorporation and cell proliferation is associated with increased PKC, eNOS, and MEK1/2, but decreased SOD activity, and higher intracellular levels of cGMP, cAMP and Ca2+ in HUVECs. These are cellular mechanisms which may reduce endothelial cell growth in pathological conditions such as in diabetes mellitus or hyperglycaemia.     

3种钙激动剂促培养的大鼠血管平滑肌细胞增殖

目的：探讨不同来源的细胞内钙离子（[Ca²⁺]i）对血管平滑肌细胞（vascular smooth muscle cells, VSMCs）丝裂素活化蛋白激酶（MAPK）介导的增殖反应的作用。方法：以培养的大鼠VSMCs为靶细胞,用血管紧张素II（Ang Ⅱ）剌激VSMCs跨膜Ca²⁺内流、三磷酸肌醇（IP₃）和雷尼丁（RY）剌激胞内Ca²⁺释放,[γ-³² P]-ATP掺入法和免疫印迹（Western blot）测MAPK活性及蛋白含量,氚-亮氨酸（[³H]-Leu）、氚-胸腺嘧啶（[³H]-TdR）掺入量作为VSMCs增殖的指标。结果：Ang Ⅱ、IP₃和RY均能显著增加VSMCs的[Ca²⁺]i浓度、MAPK活性及蛋白含量,并提高[³H]-Leu、[³H]-TdR掺入量,与对照组VSMCs相比差异显著（P<0.01）。结论：钙激动剂诱导的MAPK活性及含量的增加参与了VSMCs的增殖,VSMCs的肥大增殖与[Ca²⁺]i浓度增加有关,而与[Ca²⁺]i的来源无关。     

Modulation of phosphoinositide metabolism in aortic smooth muscle cells by allylamine

Aortic smooth muscle cells (SMC) modulate from a contractile to a proliferative phenotype upon subchronic exposure to allylamine. The present studies were designed to determine if this phenotypic modulation is associated with alterations in the metabolism of membrane phosphoinositides. 32P incorporation into phosphatidylinositol 4-phosphate (PIP), phosphatidylinositol 4,5-bisphosphate (PIP2), and phosphatidic acid (PA) was lower by 31, 35, and 22%, respectively, in SMC from allylamine-treated animals relative to controls. In contrast, incorporation of [3H]myoinositol into inositol phosphates did not differ in allylamine cells relative to control cells. Exposure to dibutyryl (db) cAMP (0.2 mM) and theophylline (0.1 mM) reduced 32P incorporation into PIP and PIP2 in SMC from both experimental groups. Under these conditions, a decrease in [3H]myoinositol incorporation into inositol 1-phosphate was only observed in allylamine cells. The effects of db cAMP and theophylline in allylamine and control SMC correlated with a marked decrease in cellular proliferation. These results suggest that alterations in phosphoinositide synthesis and/or degradation contribute to the enhanced proliferation of SMC induced by allylamine. To further examine this concept, the effects of agents which modulate protein kinase C (PKC) activity were evaluated. Sphingosine (125-500 ng/ml), a PKC inhibitor, decreased SMC proliferation in allylamine, but not control cells. 12-O-Tetradecanoylphorbol-13-acetate (1-100 ng/ml), a PKC agonist, stimulated proliferation in control cells, but inhibited proliferation in cells from allylamine-treated animals. We conclude that allylamine-induced phenotypic modulation of SMC is associated with alterations in phosphoinositide metabolism.     

SOCS3基因对缺氧大鼠肺动脉平滑肌细胞原癌基因c-myc mRNA表达及细胞增殖的影响

目的：探讨SOCS3基因对缺氧大鼠肺动脉平滑肌细胞（PASMCs）原癌基因c-myc mRNA表达及细胞增殖的影响。 方法： 以脂质体为载体将pEFSOCS3和pSV2neo共转染至体外培养的PASMCs，G418筛选阳性克隆，应用免疫细胞化学法测定转染前后细胞中SOCS3蛋白表达；缺氧处理转染组和对照组PASMCs，采用半定量RT-PCR检测转染前后常氧组、缺氧培养2 h、6 h、12 h、16 h、24 h细胞c-myc mRNA表达水平变化；［3H］-TdR掺入法检测转染前后上述各时点细胞增殖情况。 结果： 免疫细胞化学法证实转染后细胞中有SOCS3稳定表达；半定量RT-PCR结果显示，SOCS3基因转染组细胞c-myc mRNA表达水平在缺氧各时点均显著低于同时点对照组细胞（P<0.01）；SOCS3基因转染组细胞在常氧和缺氧各时点［3H］-TdR掺入量显著低于对照组细胞（P<0.01）。 结论： SOCS3蛋白可能通过下调c-myc基因表达从而抑制缺氧诱导的PASMCs增殖。     

Effects of Iptakalim on intracellular free calcium concentration of cultured rabbit pulmonary arterial smooth muscle cells

Objective:To explore the effects of Iptakalim on intracellular free calcium concentration and on the proliferation of cultured rabbit pulmonary arterial smooth muscle cells induced by endothelin-1(ET-1) in vitro. Methods:A cell culture model, [3H]-thymidine([3H]-TdR) incorporation test and confocal microscope were used to observe proliferation and intracellular free calcium concentration([Ca2+]i) of rabbit PASMC induced by ET-1 in vitro. Results:The value of [3H]-TdR incorporation in ET-1 group was increased 1.468 times higher than that in control group. Iptakalim at the concentration of 10-7mol/L,10-6 mol/L,10-5 mol/L lowered [3H]-TdR incorporation by (19.8±4.6)%, (41.2±9.5)%, (54.7±10.1)%, respectively, compared with the value of the cells treated with ET-1(P＜0.01); The intracellular fluorescence intensity of PASMC in ET-1 group was increased from 73.70±10.12 to 143.84±28.23, significantly higher than that in control group(P＜0.01); whereas with Iptakalim,the fluorescence intensity(FI) was only increased from 74.30±10.20 to 86.03±9.82, significantly lower than that in ET-1 group(P＜0.01). Conclusion:Iptakalim inhibited proliferation of PASMC and decreased intracellular free calcium concentration of cultured rabbit PASMC induced by ET-1.